| View |
|
DRP-13242
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
P-Pertaz
|
4 g/ 500 mg
|
Powder for Solution for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
10 January 2023
|
10 January 2028
|
| View |
|
DRP-13184
|
Etoposide
|
Saphtoside
|
20mg/mL (100mg/5mL)
|
Solution For I.V Injection
|
-
|
Bruck Pharma Private Limited
|
India
|
Initial
|
05 January 2023
|
05 January 2028
|
| View |
|
DR-XY48562
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Tapimycin
|
4g/500 mg
|
Powder for Injection (IV)
|
-
|
Yung Shin Pharm. Ind. Co., Ltd. (Taichung Youth Factory III)
|
Taiwan
|
Initial
|
10 January 2023
|
10 January 2028
|
| View |
|
DRP-13248
|
Chloramphenicol
|
NONE
|
5 mg/mg (0.5% w/v)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
Initial
|
10 January 2023
|
10 January 2028
|
| View |
|
DRP-13243
|
Eplerenone
|
Eplidoc
|
25 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
09 January 2023
|
09 January 2028
|
| View |
|
BR-1436
|
Atezolizumab
|
Tecentriq
|
1200 mg/20 mL (60 mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
-
|
F. Hoffmann-La Roche AG
|
Switzerland
|
Monitored Release
|
11 January 2023
|
11 January 2028
|
| View |
|
DRP-13238
|
Ursodeoxycholic Acid
|
Ursokon
|
250 mg
|
Capsules
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
06 January 2023
|
06 January 2028
|
| View |
|
DRP-13237
|
Ursodeoxycholic Acid
|
Ursokon
|
500 mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
06 January 2023
|
06 January 2028
|
| View |
|
DRP-13249
|
Hydrocortisone (As Sodium Succinate)
|
Hytrix
|
100 mg
|
Powder For Injection (I.M. /I.V.)
|
-
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
10 January 2023
|
10 January 2028
|
| View |
|
DR-XY48554
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine
Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin
B12)
|
Debion
|
100 mg / 200 mg / 200 mcg
|
Film-Coated Tablet
|
Vitamins
|
Delta Pharma Ltd.
|
Bangladesh
|
Initial (OTC)
|
06 January 2023
|
06 January 2028
|
| View |
|
DRP-13246
|
5% Dextrose in Water
|
Saph-D5
|
5 g/100 mL (5% w/v)
|
Solution for I.V. Infusion
|
-
|
Jedux Parenteral Private Limited
|
India
|
Initial (Correction)
|
25 April 2023
|
10 January 2028
|
| View |
|
DRP-13245
|
Bromhexine Hydrochloride
|
Bromhexsaph-8
|
8 mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
|
Initial (correction)
|
23 March 2023
|
10 January 2028
|
| View |
|
DR-XY48569
|
Ascorbic Acid
|
Doctri-Cee
|
533.40 mg (equivalent to 600 mg as Sodium Ascorbate)
|
Capsule
|
-
|
Theramedic Laboratories Corp.
|
Philippines
|
Initial (OTC)
|
11 January 2023
|
11 January 2028
|
| View |
|
DR-XY48555
|
Leflunomide
|
Lemard-20
|
20 mg
|
Film-Coated Tablet
|
Immunosuppressant
|
Ipca Laboratories Limited
|
India
|
Monitored Release (Correction)
|
26 July 2024
|
06 January 2028
|
| View |
|
DRP-13228
|
Febuxostat
|
Febsan 40
|
40 mg
|
Film Coated Tablet
|
Antihyperuricemia
|
ACME Formulations Pvt.Ltd
|
India
|
Renewal
|
11 August 2024
|
29 October 2029
|
| View |
|
DRP-13227
|
Febuxostat
|
Febsan 80
|
80 mg
|
Film Coated Tablet
|
Antihyperuricemia
|
ACME Formulations Pvt.Ltd
|
India
|
Renewal
|
28 August 2024
|
29 October 2029
|
| View |
|
DRP-13226
|
Febuxostat
|
Febsan 120
|
120 mg
|
Film Coated Tablet
|
Antihyperuricemia
|
ACME Formulations Pvt.Ltd
|
India
|
Renewal
|
28 August 2024
|
29 October 2029
|
| View |
|
DRHR-2187
|
Ethyl Alcohol
|
Pureform
|
70% (v/v)
|
Solution
|
-
|
Christian Cosmetic Science Inc.
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRP-13252
|
Dextromethorphan Hydrobromide + Guaifenesin
|
Guadesyn
|
15 mg/100 mg per 5 mL
|
Syrup
|
Antitussive/Expectorant
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
11 January 2023
|
11 January 2028
|
| View |
|
DRP-13231
|
Racecadotril
|
Hydril
|
30 mg
|
Granules For Oral Suspension
|
Antidiarrheal
|
Athena Drug Delivery Solutions Pvt. Ltd.
|
India
|
Renewal
|
25 July 2024
|
05 January 2030
|